Visit https://www.peervoice.com/YAP860 to view the entire programme with slides. After completing “Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis”, participants will be able to: Describe the non-oncotic properties of human albumin and how they relate to the pathology of decompensated cirrhosis; Define the importance of the dosing and administration regimen for human albumin in patients with decompensated cirrhosis and the evidence that supports this approach; Apply practical strategies to identify those patients who will benefit most from a human albumin plus standard medical therapy (SMT) regimen.